Erratum: Die TIDieR Checkliste und Anleitung - Ein Instrument für eine verbesserte interventionsbeschreibung und replikation (Gesundheitswesen (2016) (78) DOI: 10.1055/s-0041-111066);Erratum: Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide (Gesundheitswesen (2016) (78) DOI: 10.1055/s-0041-111066);Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide;Die TIDieR Checkliste und Anleitung - ein Instrument für eine verbesserte Interventionsbeschreibung und Replikation

Gesundheitswesen

Volumn 78, Issue 3, 2016, Pages 175-188

  Hoffmann, T C ^a   Glasziou, P P ^a   Boutron, I ^b   Milne, R ^c   Perera, R ^d   Moher, D ^e   Altman, D G ^f   Barbour, V ^g   MacDonald, H ^h   Johnston, M ⁱ   Lamb, S E ^f   Dixon Woods, M ^j   McCulloch, P ^f   Wyatt, J C ^k   Chan Phelan, A W ^l   Michie, S ^m   Voigt Radloff, Sebastian ⁿ  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g PLOS   (Australia)

^h British Medical Journal Technology Assessment Group   (United Kingdom)

ⁱ UNIVERSITY OF ABERDEEN   (United Kingdom)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

^k UNIVERSITY OF LEEDS   (United Kingdom)

^l UNIVERSITY OF TORONTO   (Canada)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ NONE   (Germany)

more..

Author keywords

intervention description; replicability; reporting guidelines

Indexed keywords

CHECKLIST; EDITOR; HUMAN; HUMAN EXPERIMENT; STUDY DESIGN; ALGORITHM; DISEASE MANAGEMENT; DOCUMENTATION; EVIDENCE BASED MEDICINE; GERMANY; INFORMATION PROCESSING; MEDICAL RECORD; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; STANDARDS;

ALGORITHMS; CHECKLIST; DISEASE MANAGEMENT; DOCUMENTATION; EVIDENCE-BASED MEDICINE; FORMS AND RECORDS CONTROL; GERMANY; GUIDELINE ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; RECORDS AS TOPIC;

EID: 84957099461     PISSN: 09413790     EISSN: 14394421     Source Type: Journal    
DOI: 10.1055/s-0037-1600948     Document Type: Erratum

References (30)

1. Duff J., Leather H., Walden E. et al. Adequacy of published oncology randomised controlled trials to provide therapeutic details needed for clinical application. J Natl Cancer Inst: 2010; 102 702 705
2. Glasziou P., Meats E., Heneghan C. et al. What is missing from descriptions of treatment in trials and reviews? BMJ: 2008; 336 1472 1474
3. Hoffmann T., Erueti C., Glasziou P. Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ: 2013; 347 f3755
4. Schulz K., Altman D., Moher D. CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ: 2010; 340 c332
5. Schroter S., Glasziou P., Heneghan C. Quality of descriptions of treatments: a review of published randomised controlled trials. BMJ Open: 2012; 2 e001978
6. Boutron I., Moher D., Altman D. et al. Extending the CONSORT statement to randomised trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med: 2008; 148 295 310
7. MacPherson H., Altman D. G., Hammerschlag R. et al. Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. PLoS Med: 2010; 7 e1000261
8. Gagnier J., Boon H., Rochon P. et al. Reporting randomised, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med: 2006; 144 364 367
9. Chan A., Tetzlaff J., Gotzsche P. et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ: 2013; 346 e7586
10. Moher D., Schulz K., Simera I. et al. Guidance for developers of health research reporting guidelines. PLoS Med: 2010; 7 e1000217
11. Murphy M., Black N., Lamping D. et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess: 1998; 2 1 88
12. Von Elm E., Altman D., Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ: 2007; 335 806 808
13. De Bruin M., Viechtbauer W., Hospers H. et al. Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: implications for the interpretation and comparison of intervention effects. Health Psychol: 2009; 28 668 674
14. Thorpe K., Zwarenstein M., Oxman A. D. et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol: 2009; 62 464 475
15. Craig P., Dieppe P., Macintyre S. et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ: 2008; 337 a1655
16. McCleary N., Duncan E., Stewart F. et al. Active ingredients are reported more often for pharmacologic than non-pharmacologic interventions: an illustrative review of reporting practices in titles and abstracts. Trials: 2013; 14 146
17. Michie S., West R. Behaviour change theory and evidence: a presentation to Government. Health Psychol Rev: 2013; 7 1 22
18. Dixon-Woods M., Leslie M., Tarrant C. et al. Explaining Matching Michigan: an ethnographic study of a patient safety program. Implement Sci: 2013; 8 70
19. Dixon-Woods M., Bosk C., Aveling E. et al. Explaining Michigan: developing an ex post theory of a quality improvement program. Milbank Q: 2011; 89 167 205
20. Carroll C., Patterson M., Wood S. et al. A conceptual framework for implementation fidelity. Implement Sci: 2007; 2 40
21. Bellg A. J., Borrelli B., Resnick B. et al. Enhancing treatment fidelity in health behaviour change studies: best practices and recommendations from the NIH Behaviour Change Consortium. Health Psychol: 2004; 23 443 451
22. Hardeman W., Michie S., Fanshawe T. et al. Fidelity of delivery of a physical activity intervention: predictors and consequences. Psychol Health: 2008; 23 11 24
23. Spillane V., Byrne M., Byrne M. et al. Monitoring treatment fidelity in a randomised controlled trial of a complex intervention. J Adv Nursing: 2007; 60 343 352
24. Hopewell S., Ravaud P., Baron G. et al. Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ: 2012; 344 e4178
25. Hoffmann T., English T., Glasziou P. Reporting of interventions in randomised trials: an audit of journal Instructions to Authors. Trials: 2014; 15 20
26. Michie S., Fixsen D., Grimshaw J. M. et al. Specifying and reporting complex behaviour change interventions: the need for a scientific method. Implement Sci: 2009; 4 40
27. Nature For authors: manuscript formatting guide. [Internet] www.nature.com/nature/uthors/gta/index.html#a5.3.
28. Turner L., Shamseer L., Altman D. G. et al. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev: 2012; 1 60
29. Chalmers I., Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet: 2009; 374 86 89
30. Glasziou P., Altman D., Bossuyt P. et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet: 2014; 383 267 276